Characterization of the affinity of the G(M2) activator protein for glycolipids by a fluorescence dequenching assay

被引:31
作者
SmiljanicGeorgijev, N
Rigat, B
Xie, B
Wang, W
Mahuran, DJ
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA
[2] UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO,ON M5G 1L5,CANADA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1997年 / 1339卷 / 02期
基金
加拿大健康研究院;
关键词
ganglioside transport protein; sphingolipid activator protein; SAP; lysosomal protein; hexosaminidase; G(M2) gangliosidosis;
D O I
10.1016/S0167-4838(97)00002-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The G(M2) activator protein is a substrate specific cofactor for degradation of G(M2) ganglioside by lysosomal beta-hexosaminidase A. Mutations in the gene encoding the activator result in the AB-variant form of G(M2) gangliosidosis, The activator protein contains at least three functional elements; a hydrophobic binding pocket, an oligosaccharide binding site(s), and an area that interacts with hexosaminidase A. In this report a fluorescence dequenching assay specific for only the hydrophobic binding pocket is evaluated and optimized. It is shown that various glycolipids inhibit the transport between liposomes of a self-quenching fluorescent lipid probe, octadecylrhodamine, by the activator protein. The level of inhibition produced by each glycolipid is then used to characterize the oligosaccharide-binding specificity of the activator. The fluorescence dequenching assay is also used to evaluate the functionality of a truncated form of the activator protein. Our results indicate that this simple assay can be used to determine structure-function relationships within the normal or mutant forms of the activator. The data suggest that the C-terminus of the activator is required to produce a functional hydrophobic binding pocket.
引用
收藏
页码:192 / 202
页数:11
相关论文
共 31 条
[1]   MOLECULAR-FORMS OF GM2-ACTIVATOR PROTEIN - A STUDY ON ITS BIOSYNTHESIS IN HUMAN-SKIN FIBROBLASTS [J].
BURG, J ;
BANERJEE, A ;
SANDHOFF, K .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1985, 366 (09) :887-891
[2]   MAPPING OF THE GENE CODING FOR THE HUMAN GM2 ACTIVATOR PROTEIN TO CHROMOSOME-5 [J].
BURG, J ;
CONZELMANN, E ;
SANDHOFF, K ;
SOLOMON, E ;
SWALLOW, DM .
ANNALS OF HUMAN GENETICS, 1985, 49 (JAN) :41-45
[3]   PURIFICATION AND CHARACTERIZATION OF AN ACTIVATOR PROTEIN FOR THE DEGRADATION OF GLYCOLIPID-GM2 AND GLYCOLIPID-GA2 BY HEXOSAMINIDASE-A [J].
CONZELMANN, E ;
SANDHOFF, K .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1979, 360 (12) :1837-1849
[4]   COMPLEXING OF GLYCOLIPIDS AND THEIR TRANSFER BETWEEN MEMBRANES BY THE ACTIVATOR PROTEIN FOR DEGRADATION OF LYSOSOMAL GANGLIOSIDE GM2 [J].
CONZELMANN, E ;
BURG, J ;
STEPHAN, G ;
SANDHOFF, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 123 (02) :455-464
[5]   THE ROLE OF THE GANGLIOSIDE-G(D1A) AS A RECEPTOR FOR SENDAI VIRUS [J].
EPAND, RM ;
NIR, S ;
PAROLIN, M ;
FLANAGAN, TD .
BIOCHEMISTRY, 1995, 34 (03) :1084-1089
[6]   THE COMPLETE AMINO-ACID-SEQUENCES OF HUMAN GANGLIOSIDE GM2 ACTIVATOR PROTEIN AND CEREBROSIDE SULFATE ACTIVATOR PROTEIN [J].
FURST, W ;
SCHUBERT, J ;
MACHLEIDT, W ;
MEYER, HE ;
SANDHOFF, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 192 (03) :709-714
[7]   ACTIVATOR PROTEINS AND TOPOLOGY OF LYSOSOMAL SPHINGOLIPID CATABOLISM [J].
FURST, W ;
SANDHOFF, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1126 (01) :1-16
[8]  
Gravel RA., 1995, The metabolic and molecular bases of inherited disease, V7th, P2839
[9]   CHARACTERIZATION OF FULL-LENGTH CDNAS AND THE GENE CODING FOR THE HUMAN GM2 ACTIVATOR PROTEIN [J].
KLIMA, H ;
TANAKA, A ;
SCHNABEL, D ;
NAKANO, T ;
SCHRODER, M ;
SUZUKI, K ;
SANDHOFF, K .
FEBS LETTERS, 1991, 289 (02) :260-264
[10]   OVER-EXPRESSION OF A FUNCTIONALLY ACTIVE HUMAN G(M2)-ACTIVATOR PROTEIN IN ESCHERICHIA-COLI [J].
KLIMA, H ;
KLEIN, A ;
VANECHTEN, G ;
SCHWARZMANN, G ;
SUZUKI, K ;
SANDHOFF, K .
BIOCHEMICAL JOURNAL, 1993, 292 :571-576